Hacker News new | ask | show | jobs
by jyounker 4 days ago
> I don't think any of this can be changed without large-scale social acceptance of greater risk in clinical trials and significant support from the government.

I agree with you about significant financial support from the government if that support is financial and given to smaller groups.

I disagree about societal acceptance though. I feel like your point of view may be missing clinical trials and treatments in the USA. The laws we have are written in blood, and the laws more sophisticated than I think you appreciate.

There are various options for fast-tracking drug development if the conditions are serious enough or the drugs promising enough. I suggest actually reading about how these processes work, and the history of what happens when we don't have these protections, before deciding that approvals are overly cautious.

1 comments

You are explaining clinical trials to somebody who works in pharma (speccifically a company with many cancer drugs that already got approved). I'm pretty familiar with the area already- for example, I know the drug thalidomide, which was part of the origin story of the FDA, is still prescribed widely as an anti-cancer drug.